High MET expression is an adverse prognostic factor in patients with triple-negative breast cancerFlora Zagouri, Martin Filipits, Constantine Dimitrakakis et al.|British Journal of Cancer|2013Cited by 98
Impact of RANK signalling on survival and chemotherapy response in osteosarcomaZsuzsanna Bagó-Horváth, Irene Sulzbacher, Katharina Schmid et al.|Pathology|2014Cited by 40
Factors influencing agreement of breast cancer luminal molecular subtype by Ki67 labeling index between core needle biopsy and surgical resection specimensKristina Tendl-Schulz, Zsuzsanna Bagó-Horváth, Thomas H. Helbich et al.|Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin|2020Cited by 8